Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis

OBJECTIVE: The purpose of this study was to assess the efficacy and hypoglycemic risk of sitagliptin versus that of GLP-1 receptor agonists in the management of obese/overweight patients with T2DM. METHODS: EMBASE, PubMed, Cochrane Library, and ClinicalTrials.gov were searched; randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Danping, Mao, Yiyang, Jin, Haiying, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739021/
https://www.ncbi.nlm.nih.gov/pubmed/31490412
http://dx.doi.org/10.1097/MD.0000000000017081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739021/
https://www.ncbi.nlm.nih.gov/pubmed/31490412
http://dx.doi.org/10.1097/MD.0000000000017081

Ejemplares similares